Sun Pharmaceutical Industries Inc. recalled Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg on Jan. 13, 2023, after failed impurity and dissolution testing, according to the FDA.
How to tell if you have it
- Brand: Sun Pharmaceutical
- Product: Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg
- Packaging: 90-count bottles
- NDC: 47335-679-81
- Lot codes: HAC3120A (Exp. 04/2023), HAC3121A (Exp. 10/2023), HAC4460A (Exp. 12/2023), HAD0365A (Exp. 02/2024), HAD1452A (Exp. 02/2024)
- Distribution: Nationwide in the U.S.
The hazard
The recall was issued due to failed impurity specifications for Deacetyl Diltiazem Hydrochloride during stability testing and failed dissolution testing at an FDA laboratory.
Context
GovInfoNow's records show Sun Pharmaceutical Industries Inc. has 93 other recalls on record since May 21, 2013. Other recent recalls of similar products include Sun Pharmaceutical Nystatin Cream Recall (Sept. 14, 2026), Sun Pharmaceutical Carbamazepine Tablets Recall (Aug. 3, 2026), and Sun Pharmaceutical Perampanel 6mg Tablets Recall (June 17, 2026).